Synthorx, Inc. Common Stock
THOR
THOR was delisted on the 22nd of January, 2020.
0 hedge funds and large institutions have $0 invested in Synthorx, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 103 closing their positions.
100% less funds holding
Funds holding: 103 → 0 (-103)
100% less funds holding in top 10
Funds holding in top 10: 8 → 0 (-8)
100% less capital invested
Capital invested by funds: $1.7B → $0 (-$1.7B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 103
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$680M |
| 2 |
O
OrbiMed
New York
|
-$372M |
| 3 |
MVM
Medicxi Ventures Management
St. Helier,
Jersey
|
-$70.3M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$69.9M |
| 5 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$64.9M |
THOR Hedge Fund Activity: Q1 2020 in Review
0 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Synthorx, Inc. Common Stock (THOR) for Q1 2020, worth a combined $0 — down 100% from $1.7B a quarter earlier.
Sellers outnumbered buyers: 103 funds closed out of THOR and 0 opened new positions — a net loss of 103 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was RA Capital Management, exiting entirely with an estimated $680M sold.
- 0 institutional investors held Synthorx, Inc. Common Stock (THOR) as of Q1 2020, down from 103 in Q4 2019.
- Funds reported $0 of Synthorx, Inc. Common Stock stock for Q1 2020, down 100% quarter-over-quarter.
- 0 funds opened new Synthorx, Inc. Common Stock positions in Q1 2020 and 103 closed out, a net change of -103 holders.
- The largest Synthorx, Inc. Common Stock seller in Q1 2020 was RA Capital Management, an estimated $680M sold.
Based on aggregated 13F filings for Q1 2020.